Douglas Lane & Associates, LLC Novo Nordisk A S Transaction History

Douglas Lane & Associates, LLC

$7.1 Billion
Q3 2024

A detailed history of Douglas Lane & Associates, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 4,805 shares of NVO stock, worth $488,860. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,805

Previous 4,805 -0.0%

Holding current value

$488,860

Previous $685,000 16.5%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 08, 2024	BUY	$122.71 - $146.91 $7,730 - $9,255	63 Added 1.33%	4,805 $685,000
Q4 2023 Jan 17, 2024	SELL	$87.78 - $105.45 $17,556 - $21,090	-200 Reduced 4.05%	4,742 $490,000
Q3 2023 Oct 16, 2023	BUY	$90.94 - $199.54 $220,165 - $483,086	2,421 Added 96.03%	4,942 $449,000
Q1 2023 Apr 17, 2023	SELL	$132.34 - $159.14 $6,087 - $7,320	-46 Reduced 1.79%	2,521 $401,000
Q4 2022 Jan 17, 2023	SELL	$102.55 - $135.33 $69,631 - $91,889	-679 Reduced 20.92%	2,567 $347,000
Q3 2022 Oct 14, 2022	SELL	$95.28 - $116.93 $14,292 - $17,539	-150 Reduced 4.42%	3,246 $323,000
Q1 2022 Apr 25, 2022	SELL	$93.1 - $112.54 $3,072 - $3,713	-33 Reduced 0.96%	3,396 $377,000
Q4 2021 Jan 25, 2022	SELL	$95.88 - $117.08 $7,191 - $8,781	-75 Reduced 2.14%	3,429 $384,000
Q2 2021 Jul 19, 2021	SELL	$67.66 - $84.76 $23,681 - $29,666	-350 Reduced 9.08%	3,504 $294,000
Q1 2021 Apr 19, 2021	SELL	$67.06 - $75.82 $3,353 - $3,790	-50 Reduced 1.28%	3,854 $260,000
Q4 2020 Jan 14, 2021	BUY	$63.89 - $73.8 $3,194 - $3,690	50 Added 1.3%	3,904 $273,000
Q3 2020 Oct 19, 2020	SELL	$63.69 - $70.22 $11,782 - $12,990	-185 Reduced 4.58%	3,854 $268,000
Q2 2020 Jul 28, 2020	BUY	$58.54 - $67.94 $31,026 - $36,008	530 Added 15.1%	4,039 $264,000
Q1 2020 Apr 20, 2020	SELL	$49.46 - $64.78 $153,375 - $200,882	-3,101 Reduced 46.91%	3,509 $211,000
Q4 2019 Jan 27, 2020	BUY	$49.86 - $58.26 $10,470 - $12,234	210 Added 3.28%	6,610 $383,000
Q2 2019 Jul 08, 2019	SELL	$46.79 - $52.47 $84,362 - $94,603	-1,803 Reduced 21.98%	6,400 $327,000
Q4 2018 Jan 17, 2019	BUY	$41.54 - $47.25 $340,752 - $387,591	8,203 New	8,203 $378,000
Q4 2017 Jan 24, 2018	SELL	$47.53 - $53.73 $349,583 - $395,184	-7,355 Closed	0 $0
Q3 2017 Oct 19, 2017	BUY	$41.15 - $49.22 $302,658 - $362,013	7,355	7,355 $354,000

Others Institutions Holding NVO

# of Institutions

1,953

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $230B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.

Account

Douglas Lane & Associates, LLC Novo Nordisk A S Transaction History